These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21183275

  • 1. Thyroid hormone as a regulator of tumor induced angiogenesis.
    Pinto M, Soares P, Ribatti D.
    Cancer Lett; 2011 Feb 28; 301(2):119-26. PubMed ID: 21183275
    [Abstract] [Full Text] [Related]

  • 2. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
    Lin HY, Cody V, Davis FB, Hercbergs AA, Luidens MK, Mousa SA, Davis PJ.
    Discov Med; 2011 Apr 28; 11(59):337-47. PubMed ID: 21524387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
    Lin HY, Su YF, Hsieh MT, Lin S, Meng R, London D, Lin C, Tang HY, Hwang J, Davis FB, Mousa SA, Davis PJ.
    FASEB J; 2013 Aug 28; 27(8):3209-16. PubMed ID: 23640055
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
    Cohen K, Ellis M, Khoury S, Davis PJ, Hercbergs A, Ashur-Fabian O.
    Mol Cancer Res; 2011 Oct 28; 9(10):1385-94. PubMed ID: 21821675
    [Abstract] [Full Text] [Related]

  • 8. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.
    Liu YC, Yeh CT, Lin KH.
    Int J Mol Sci; 2019 Oct 09; 20(20):. PubMed ID: 31600974
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ.
    Angiogenesis; 2008 Oct 09; 11(2):183-90. PubMed ID: 18080776
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology.
    Hercbergs AH, Ashur-Fabian O, Garfield D.
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct 09; 17(5):432-6. PubMed ID: 20689420
    [Abstract] [Full Text] [Related]

  • 14. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
    Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK.
    Am J Physiol Endocrinol Metab; 2009 Dec 09; 297(6):E1238-46. PubMed ID: 19755667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Short-term effects of thyroid hormones during development: Focus on signal transduction.
    Scapin S, Leoni S, Spagnuolo S, Gnocchi D, De Vito P, Luly P, Pedersen JZ, Incerpi S.
    Steroids; 2010 Dec 09; 75(8-9):576-84. PubMed ID: 19900468
    [Abstract] [Full Text] [Related]

  • 19. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
    Lin HY, Mousa SA, Davis PJ.
    Methods Mol Biol; 2018 Dec 09; 1801():61-65. PubMed ID: 29892817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.